Holly Bastian is a Rheumatology/Immunology physician. OpenAlex indexes 46 publications with 5,301 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1201 Arista Dr Ste 105
Rockwall, TX 750326860
Telephone
972-664-0644Provider last certified this registry record 13 Sept 2021.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Amgen Inc.Program year20244 payments
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
49.1%Folate Analog Metabolic Inhibitor30%Methotrexate100%Part D≥46 patientsAntirheumatic Agent14.3%Leflunomide100%Part D≥21 patients+ 1 more class in this area
Antiparasitic
26.7%Antimalarial26.7%Hydroxychloroquine Sulfate100%Part D≥37 patientsMetabolism & gastrointestinal
24.2%Aminosalicylate12.5%Sulfasalazine50%Sulfasalazine Dr50%Part D<11 patientsCorticosteroid11.7%Prednisone100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Systemic Lupus Erythematosus in a Multiethnic US Cohort, LUMINA (XLIX)
JCR Journal of Clinical Rheumatology
2008 - Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)
Annals of the Rheumatic Diseases
2007
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”